| 2024 | Rethinking extent of resection of contrast-enhancing and non-enhaning tumor: different survival impacts on adult-type diffuse gliomas in 2021 World Health Organization classification | EUROPEAN RADIOLOGY |
| 2024 | 11C-Acetate PET/CT for Reactive Astrogliosis Outperforms 11C-Methionine PET/CT in Glioma Classification and Survival Prediction | CLINICAL NUCLEAR MEDICINE |
| 2024 | High Radiation Dose to the Fornix Causes Symptomatic Radiation Necrosis in Patients with Anaplastic Oligodendroglioma
| YONSEI MEDICAL JOURNAL |
| 2023 | Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme | JOURNAL OF NEURO-ONCOLOGY |
| 2023 | Dynamic contrast-enhanced MRI radiomics model predicts epidermal growth factor receptor amplification in glioblastoma, IDH-wildtype | JOURNAL OF NEURO-ONCOLOGY |
| 2023 | Novel Postoperative Serum Biomarkers in Atypical Meningiomas: A Multicenter Study | NEUROSURGERY |
| 2023 | Classification of IDH wild-type glioblastoma tumorspheres into low- and high-invasion groups based on their transcriptional program | BRITISH JOURNAL OF CANCER |
| 2023 | Leptomeningeal metastases in glioma revisited: incidence and molecular predictors based on postcontrast fluid-attenuated inversion recovery imaging | JOURNAL OF NEUROSURGERY |
| 2023 | The Korean Society for Neuro-Oncology (KSNO) Guideline for the Management of Brain Tumor Patients During the Crisis Period: A Consensus Recommendation Using the Delphi Method (Version 2023.3)
| Brain Tumor Research and Treatment |
| 2023 | Revisiting prognostic factors in glioma with leptomeningeal metastases: a comprehensive analysis of clinical and molecular factors and treatment modalities
| JOURNAL OF NEURO-ONCOLOGY |
| 2023 | Mesenchymal Stem-Like Cells Derived from the Ventricle More Effectively Enhance Invasiveness of Glioblastoma Than Those Derived from the Tumor | YONSEI MEDICAL JOURNAL |
| 2022 | Dual inhibition of CPT1A and G6PD suppresses glioblastoma tumorspheres | JOURNAL OF NEURO-ONCOLOGY |
| 2022 | Adding radiomics to the 2021 WHO updates may improve prognostic prediction for current IDH-wildtype histological lower-grade gliomas with known EGFR amplification and TERT promoter mutation status | EUROPEAN RADIOLOGY |
| 2022 | Assessing Spatial Distribution of Multicellular Self-Assembly Enables the Prediction of Phenotypic Heterogeneity in Glioblastoma
| CANCERS |
| 2022 | Two independent variants of epidermal growth factor receptor associated with risk of glioma in a Korean population
| SCIENTIFIC REPORTS |
| 2022 | Tissue Niche Miniature of Glioblastoma Patient Treated with Nano-Awakeners to Induce Suicide of Cancer Stem Cells | ADVANCED HEALTHCARE MATERIALS |
| 2022 | 11 C-Acetate PET/CT Detects Reactive Astrogliosis Helping Glioma Classification | CLINICAL NUCLEAR MEDICINE |
| 2022 | Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres
| CANCER CELL INTERNATIONAL |
| 2022 | Sex as a prognostic factor in adult-type diffuse gliomas: an intergrated clinical and molecular analysis according to the 2021 WHO classification | JOURNAL OF NEURO-ONCOLOGY |
| 2022 | A lignan from Alnus japonica inhibits glioblastoma tumorspheres by suppression of FOXM1
| SCIENTIFIC REPORTS |
| 2022 | Patterns of recurrence according to the extent of resection in patients with IDH-wild-type glioblastoma: a retrospective study | JOURNAL OF NEUROSURGERY |
| 2022 | Glioblastoma-educated mesenchymal stem-like cells promote glioblastoma infiltration via extracellular matrix remodelling in the tumour microenvironment
| CLINICAL AND TRANSLATIONAL MEDICINE |
| 2022 | Adjuvant Radiotherapy Versus Surveillance for Grade 2 Intracranial Meningiomas: A Multi-Institutional Propensity Score-Matched Study
| FRONTIERS IN ONCOLOGY |
| 2022 | A fully automatic multiparametric radiomics model for differentiation of adult pilocytic astrocytomas from high-grade gliomas | EUROPEAN RADIOLOGY |
| 2022 | Recent Update on Neurosurgical Management of Brain Metastasis
| Brain Tumor Research and Treatment |
| 2022 | Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study)
| CANCER RESEARCH AND TREATMENT |
| 2022 | Quenching Epigenetic Drug Resistance Using Antihypoxic Microparticles in Glioblastoma Patient-Derived Chips | ADVANCED HEALTHCARE MATERIALS |
| 2022 | Clinical and diffusion parameters may noninvasively predict TERT promoter mutation status in grade II meningiomas | JOURNAL OF NEURORADIOLOGY |
| 2022 | Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open-label phase 2 study
| CANCER MEDICINE |
| 2022 | Quality of Radiomics Research on Brain Metastasis: A Roadmap to Promote Clinical Translation
| KOREAN JOURNAL OF RADIOLOGY |
| 2022 | A novel biguanide (IM1761065) inhibits bioenergetics of glioblastoma tumorspheres | JOURNAL OF NEURO-ONCOLOGY |
| 2022 | Soluble ICAM-1 a Pivotal Communicator between Tumors and Macrophages, Promotes Mesenchymal Shift of Glioblastoma
| ADVANCED SCIENCE |
| 2021 | A novel paper MAP method for rapid high resolution histological analysis
| SCIENTIFIC REPORTS |
| 2021 | Radiomics-based prediction of multiple gene alteration incorporating mutual genetic information in glioblastoma and grade 4 astrocytoma, IDH-mutant
| JOURNAL OF NEURO-ONCOLOGY |
| 2021 | Stereotactic biopsy for adult brainstem lesions: A surgical approach and its diagnostic value according to the 2016 World Health Organization Classification
| CANCER MEDICINE |
| 2021 | Dynamic contrast-enhanced MRI may be helpful to predict response and prognosis after bevacizumab treatment in patients with recurrent high-grade glioma: comparison with diffusion tensor and dynamic susceptibility contrast imaging | NEURORADIOLOGY |
| 2021 | Anterior skull base reconstruction using an anterolateral thigh free flap
| Archives of Craniofacial Surgery |
| 2021 | K-RAS Acts as a Critical Regulator of CD44 to Promote the Invasiveness and Stemness of GBM in Response to Ionizing Radiation
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2021 | Endoscopic transorbital approach to the insular region: cadaveric feasibility study and clinical application (SevEN-005) | JOURNAL OF NEUROSURGERY |
| 2021 | A diagnostic tree for differentiation of adult pilocytic astrocytomas from high-grade gliomas | EUROPEAN JOURNAL OF RADIOLOGY |
| 2021 | Influence of the Amount of Fresh Specimen on the Isolation of Tumor Mesenchymal Stem-Like Cells from High-Grade Glioma
| YONSEI MEDICAL JOURNAL |
| 2021 | Efficacy of Whole-Ventricular Radiotherapy in Patients Undergoing Maximal Tumor Resection for Glioblastomas Involving the Ventricle
| FRONTIERS IN ONCOLOGY |
| 2021 | Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma
| JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH |
| 2021 | Magnetic Resonance Imaging Parameters for Noninvasive Prediction of Epidermal Growth Factor Receptor Amplification in Isocitrate Dehydrogenase-Wild-Type Lower-Grade Gliomas: A Multicenter Study | NEUROSURGERY |
| 2021 | Reply to D'Alessandris et al.: Clear evidence of differences between tumor-resident mesenchymal stemlike cells and bone marrow-derived mesenchymal stem cells | NEURO-ONCOLOGY |
| 2021 | Quality assessment of meningioma radiomics studies: Bridging the gap between exploratory research and clinical applications | EUROPEAN JOURNAL OF RADIOLOGY |
| 2021 | Sensitive label-free imaging of brain samples using FxClear-based tissue clearing technique
| ISCIENCE |
| 2021 | Differentiation of recurrent diffuse glioma from treatment-induced change using amide proton transfer imaging: incremental value to diffusion and perfusion parameters | NEURORADIOLOGY |
| 2021 | Fully automated hybrid approach to predict the IDH mutation status of gliomas via deep learning and radiomics
| NEURO-ONCOLOGY |
| 2021 | Combinatorial Therapeutic Effect of Inhibitors of Aldehyde Dehydrogenase and Mitochondrial Complex I, and the Chemotherapeutic Drug, Temozolomide against Glioblastoma Tumorspheres
| MOLECULES |
http://orcid.org/0000-0001-5676-2037
(56566963000)
